agilon health inc
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: February 27, 2024
agilon health, inc. (Registrant)
/s/ STEVEN J. SELL
Steven J. Sell,
Chief Executive Officer and President(Principal Executive Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ STEVEN J. SELL | Chief Executive Officer and President | February 27, 2024 |
| Steven J. Sell | (Principal Executive Officer), Director | |
| /s/ TIMOTHY S. BENSLEY | Executive Vice President and Chief Financial Officer | February 27, 2024 |
| Timothy S. Bensley | (Principal Financial Officer) | |
| /s/ TIMOTHY GERTSCH | Chief Accounting Officer | February 27, 2024 |
| Timothy Gertsch | (Principal Accounting Officer) | |
| /s/ RONALD A. WILLIAMS | Chairman of the Board | February 27, 2024 |
| Ronald A. Williams | ||
| /s/ RAVI SACHDEV | Vice Chairman of the Board | February 27, 2024 |
| Ravi Sachdev | ||
| /s/ SHARAD MANSUKANI, M.D. | Director | February 27, 2024 |
| Sharad Mansukani, M.D. | ||
| /s/ JEFFREY A. SCHWANEKE | Director | February 27, 2024 |
| Jeffrey A. Schwaneke | ||
| /s/ WILLIAM WULF, M.D. | Director | February 27, 2024 |
| William Wulf, M.D. | ||
| Signature | Title | Date |
|---|---|---|
| /s/ KAREN MCLOUGHLIN | Director | February 27, 2024 |
| Karen McLoughlin | ||
| /s/ DIANA L. MCKENZIE | Director | February 27, 2024 |
| Diana L. McKenzie | ||
| /s/ SILVANA BATTAGLIA | Director | February 27, 2024 |
| Silvana Battaglia | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.